Skip to content

Performance and safety evaluation of elastic nailing system

A non- randomized, prospective Post Market Clinical Follow-up study to evaluate the Safety and Performance of elastic nailing

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052536
Enrollment
30
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S723- Fracture of shaft of femur Health Condition 2: S824- Fracture of shaft of fibula Health Condition 3: S423- Fracture of shaft of humerus Health Condition 4: S523- Fracture of shaft of radius Health Condition 5: S822- Fracture of shaft of tibia Health Condition 6: S522- Fracture of shaft of ulna

Interventions

Intervention1: Elastic Nailing system: The AUXEIN MEDICALs Elastic Intramedullary Nail System is indicated for management of diaphyseal and certain metaphyseal/epiphyseal fracture of long bones in chi

Sponsors

Auxein Medical Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject legal Guardian/ Parent willing and able to give informed consent for participation in the study. Girl and Boy between 6 to 15 years. Subject diagnosed with diaphyseal fractures, metaphyseal and epiphyseal fractures of long bones.

Exclusion criteria

Exclusion criteria: Local or Systemic acute or chronic inflammation. Active infection or inflammation. Suspected or documented metal allergy or intolerance. Symptomatic Arthiritis Patient with Mental Disorders as well as comprehensive legal support. Lack of willingness to make a commitment to return for required follow up visits. Drug and/or alcohol abuse. Morbid obesity.

Design outcomes

Primary

MeasureTime frame
Fracture fusionTimepoint: at 12 months postoperatively

Secondary

MeasureTime frame
Rate of implant related, surgery related, postoperative and general complicationsTimepoint: 1, 3, 6 month

Countries

India

Contacts

Public ContactMr Gaurav Luthra

Auxein Medical Pvt. Ltd.

b.mishra@auxein.com9419660141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026